´ç´¢º´ ½ÃÀåÁ¶»çº¸°í¼­

´ç´¢º´ °ü·Ã Á¶»çº¸°í¼­¿¡¼­´Â ´ç´¢º´ °ü·Ã Á¦Ç° ½ÃÀåÀÇ Ãֽе¿Çâ¿¡ ´ëÇØ Æø³Ð°Ô ´Ù·ç¾ú½À´Ï´Ù. ¶ÇÇÑ Ä¡·á¹ý°ú Àν¶¸°, Àν¶¸° Àü´Þ ½Ã½ºÅÛ, ¿ªÇÐÀû »óȲ, ȯÀÚ Àα¸ ¹× ¿¬·É ±¸Á¶, À¯º´ÀÚ¼ö, °Ë»ç ¹æ¹ý µî¿¡ °üÇÑ »ó¼¼ÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. °¢±¹ ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ Àü¸Á¿¡ °üÇÑ º¸°í¼­µµ ´Ù¼ö ±¸ºñÇϰí ÀÖ½À´Ï´Ù.

1 - 25 (Àüü: 252°Ç)
¼¼°èÀÇ ¼Ò¾Æ ´ç´¢º´ Ä¡·áÁ¦ ½ÃÀå
Pediatric Diabetes Therapeutics
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 5,850 £Ü 8,206,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Àν¶¸° ¾Æ½ºÆÄ¸£Æ® ½ÃÀå º¸°í¼­(2025³â)
Insulin Aspart Global Market Report 2025
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,490 £Ü 6,299,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ´ç´¢º´ Ä¡·á ½ÃÀå º¸°í¼­(2025³â)
Diabetes Care Global Market Report 2025
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,490 £Ü 6,299,000 (ºÎ°¡¼¼ º°µµ)
¶õÅõ½º(Lantus) ½ÃÀå : ¿¬·ÉÃþº°, °­µµº°, Á¦Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, À¯Åë ä³Îº°, Áö¿ªº°
Lantus Market, By Age Group, By Strength, By Dosage Form, By End User, By Distribution Channel, By Geography
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 4,500 £Ü 6,313,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ´ç´¢º´¼º ÄÉÅæ»êÁõ ½ÃÀå
Diabetic Ketoacidosis
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 5,850 £Ü 8,206,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ´ç´¢º´ °ü¸®¿ë ÀΰøÁö´É(AI) ½ÃÀå
Artificial Intelligence (AI) in Diabetes Management
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 5,850 £Ü 8,206,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ´ç´¢º´¼º Á·±Ë¾ç Ä¡·áÁ¦ ½ÃÀå
Diabetic Foot Ulcer Therapeutics
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 5,850 £Ü 8,206,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ´ç´¢º´ Ä¡·áÁ¦ ½ÃÀå : ¿¹Ãø(2025-2030³â)
Global Diabetes Care Drugs Market - Forecasts from 2025 to 2030
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 3,950 £Ü 5,541,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ´ç´¢º´¼º Á·ºÎ±Ë¾ç Ä¡·á ½ÃÀå ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м® ¹× ¿¹Ãø(2025-2034³â)
Diabetic Foot Ulcer Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 4,850 £Ü 6,804,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ´ç´¢º´ ±â±â ¹× Ä¡·áÁ¦ ½ÃÀå : Ä«Å×°í¸®º°, Áúȯ À¯Çüº°, Áö¿ªº°
Diabetes Devices and Drugs Market, By Category (Diagnosis and Monitoring, Therapeutics), By Disease Type (Type 2 Diabetes, Type 1 Diabetes), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 4,500 £Ü 6,313,000 (ºÎ°¡¼¼ º°µµ)
´ç´¢º´ ÀüÁõ ½ÃÀå : ¾à¹° Á¾·ùº°, À¯Çüº°, Åõ¿© °æ·Îº°, ¿¬·ÉÃþº°, ¼ºº°, À¯Åë ä³Îº°, Áö¿ªº°
Prediabetes Market, By Drug Class, By Type, By Routes of Administration, By Age Group, By Gender, By Distribution Channel, By Geography
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 4,500 £Ü 6,313,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Àν¶¸° °¨ÀÛÁ¦ ½ÃÀå
Insulin Sensitizers
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 5,850 £Ü 8,206,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ´ç´¢º´ ÀüÁõ ½ÃÀå : Á¦Ç° À¯Çüº°, ¿¬·ÉÃþº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°, ±âȸ ¹× ¿¹Ãø(2018-2032³â)
Prediabetes Market Assessment, By Product Type, By Age Group, By End-user, By Region, Opportunities and Forecast, 2018-2032F
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 4,800 £Ü 6,733,000 (ºÎ°¡¼¼ º°µµ)
´ç´¢º´ Ä¡·á ±â±â ½ÃÀå - ±Ô¸ð, Á¡À¯À², µ¿Çâ, ¿¹Ãø : À¯Çüº°, À¯Åë ä³Îº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°(2025-2033³â)
Diabetes Care Devices Market Size, Share, Trends and Forecast by Type, Distribution Channel, End User, and Region, 2025-2033
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 2,999 £Ü 4,207,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ´ç´¢º´¼º ½ÅÀ庴 ½ÃÀå
Diabetic Kidney Diseases
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 5,850 £Ü 8,206,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ´ç´¢º´¼º À§¸¶ºñ Ä¡·á ½ÃÀå
Diabetic Gastroparesis Treatment
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 5,850 £Ü 8,206,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ´ç´¢º´ Ä¡·á¿ë ÀÓ»ó ¿µ¾ç ½ÃÀå : ½ÃÀå ±Ô¸ð ºÐ¼®(Á¦Ç°º°, º´±âº°, ÆÇ¸Å ä³Îº°, Áö¿ªº°) ¹× ¿¹Ãø(2022-2032³â)
Global Clinical Nutrition For Diabetes Care Market Size study, by Product (Oral, Enteral Feeding Formulas, Parenteral Nutrition), Stage, Sales Channel, and Regional Forecasts 2022-2032
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 4,950 £Ü 6,944,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ °æ±¸¿ë Ç×´ç´¢º´Á¦ ½ÃÀå - »ê¾÷±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø, ÀǾàǰº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Oral Anti-Diabetic Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drugs, By End Users, By Region and Competition, 2020-2030F
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 4,500 £Ü 6,313,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ 1Çü ´ç´¢º´ ½ÃÀå
Type 1 Diabetes
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 5,850 £Ü 8,206,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ³»´ç´É °Ë»ç ½ÃÀå
Glucose Tolerance Tests
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 5,850 £Ü 8,206,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ À§¸¶ºñ Ä¡·á ½ÃÀå
Gastroparesis Treatment
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 5,850 £Ü 8,206,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ´ç´¢Áö¹æ»ý±«»ç(NLD) ½ÃÀå º¸°í¼­(2025³â)
Necrobiosis Lipoidica Diabeticorum (NLD) Global Market Report 2025
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 4,490 £Ü 6,299,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ºñÁÖ»ç Àν¶¸° ½ÃÀå : »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø - Á¦Ç°º°, À¯Åë ä³Îº°, Áö¿ªº°, °æÀﺰ ºÎ¹®(2020-2030³â)
Non-Injectable Insulin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Distribution Channel, By Region and Competition, 2020-2030F
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 4,500 £Ü 6,313,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¼ÓÈ¿¼º Àν¶¸° ½ÃÀå ±Ô¸ð ¹× Á¡À¯À² ºÐ¼® - ¼ºÀå µ¿Çâ°ú ¿¹Ãø(2025-2033³â)
Rapid Acting Insulin Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 2,990 £Ü 4,194,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¼ÓÈ¿¼º Àν¶¸° ½ÃÀå º¸°í¼­(2025³â)
Short-Acting Insulin Global Market Report 2025
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 4,490 £Ü 6,299,000 (ºÎ°¡¼¼ º°µµ)
(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.